Man Group
MXCT icon

Man Group’s MaxCyte MXCT Stock Holding History

Man Group’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$552K Buy
+448,958
New +$447K ﹤0.01% 2032
2024
Q1 		– Sell
-12,836
Closed -$60.3K – 2220
2023
Q4 		$60.3K Buy
+12,836
New +$50K ﹤0.01% 2006
2022
Q2 		– Hold
0
– – – 1848

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Man Group's MXCT Position: Q2 2026 in Review

Man Group opened a new position in MaxCyte (MXCT) in Q2 2026: 448,958 shares worth $552K. The stake represents ﹤0.01% of the portfolio and ranks #2032 among its holdings. This is a return to the name: Man Group previously reported a position in MXCT as recently as Q4 2023.

Man Group first reported a position in MXCT in Q4 2023 and has held it in 2 quarters since. 123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Man Group held 448,958 shares of MaxCyte worth $552K as of Q2 2026.
  • MaxCyte was a new Man Group position in Q2 2026.
  • MaxCyte made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #2032 holding.
  • Man Group first reported a position in MaxCyte in Q4 2023 and has held it in 2 quarters since.
  • 123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.